Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tolerability and Adverse Effects of Using Multiple Doses of Ivermectin in Egypt During Covid 19 Pandemic

NCT04747678 is registered in ClinicalTrials.gov with Menoufia University as lead sponsor.

NCT NCT04747678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04747678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tolerability and Adverse Effects of Using Multiple Doses of Ivermectin in Egypt During Covid 19 Pandemic
Lead sponsor
Menoufia University
Phase
Observational
Overall status
Unknown status
Start date
February 3, 2021
Completion date
March 1, 2021
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, drug side effect, drug toxicity, ivermectin poisoning